Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma

Differentiation between adult T-cell leukemia/lymphoma (ATLL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is often challenging based on pathological findings alone. Although serum anti-HTLV-1 antibody positivity is required for ATLL diagnosis, this information is often not av...

Full description

Bibliographic Details
Main Authors: Atsuko Nasu, Yuka Gion, Yoshito Nishimura, Asami Nishikori, Misa Sakamoto, Yuria Egusa, Azusa Fujita, Tadashi Yoshino, Yasuharu Sato
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/5/766
_version_ 1797536468334280704
author Atsuko Nasu
Yuka Gion
Yoshito Nishimura
Asami Nishikori
Misa Sakamoto
Yuria Egusa
Azusa Fujita
Tadashi Yoshino
Yasuharu Sato
author_facet Atsuko Nasu
Yuka Gion
Yoshito Nishimura
Asami Nishikori
Misa Sakamoto
Yuria Egusa
Azusa Fujita
Tadashi Yoshino
Yasuharu Sato
author_sort Atsuko Nasu
collection DOAJ
description Differentiation between adult T-cell leukemia/lymphoma (ATLL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is often challenging based on pathological findings alone. Although serum anti-HTLV-1 antibody positivity is required for ATLL diagnosis, this information is often not available at the time of pathological diagnosis. Therefore, we examined whether the expression of SOX4 and p16 would be helpful for differentiating the two disease entities. We immunohistochemically examined SOX4 and p16 expression (which have been implicated in ATLL carcinogenesis) in 11 ATLL patients and 20 PTCL-NOS patients and classified them into four stages according to the percentage of positive cells. Among the ATLL cases, 8/11 (73%) were SOX4-positive, while only 2/20 (10%) PTCL-NOS cases expressed SOX4. The mean total score was 4.2 (standard deviation (SD): 0.61) in the ATLL group and 0.50 (SD: 0.46) in the PTCL-NOS group (<i>p</i> < 0.001). Positive expression of p16 was noted in 4/11 (36%) patients with ATLL and 3/20 (15%) patients with PTCL-NOS, with mean total scores of 1.9 (SD: 0.64) and 0.70 (SD: 0.48) in the ATLL and PTCL-NOS groups, respectively (<i>p</i> = 0.141). These results suggest that SOX4 may be strongly expressed in ATLL compared to PTCL-NOS cases. Therefore, it may be helpful to perform immunohistochemical staining of SOX4 when pathologists face challenges discriminating between ATLL and PTCL-NOS.
first_indexed 2024-03-10T12:01:07Z
format Article
id doaj.art-a31f219985144decb65c54912a288e77
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T12:01:07Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-a31f219985144decb65c54912a288e772023-11-21T16:59:07ZengMDPI AGDiagnostics2075-44182021-04-0111576610.3390/diagnostics11050766Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/LymphomaAtsuko Nasu0Yuka Gion1Yoshito Nishimura2Asami Nishikori3Misa Sakamoto4Yuria Egusa5Azusa Fujita6Tadashi Yoshino7Yasuharu Sato8Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDepartment of General Medicine, Okayama University Hospital, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDepartment of Pathology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama 700-8558, JapanDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, JapanDifferentiation between adult T-cell leukemia/lymphoma (ATLL) and peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is often challenging based on pathological findings alone. Although serum anti-HTLV-1 antibody positivity is required for ATLL diagnosis, this information is often not available at the time of pathological diagnosis. Therefore, we examined whether the expression of SOX4 and p16 would be helpful for differentiating the two disease entities. We immunohistochemically examined SOX4 and p16 expression (which have been implicated in ATLL carcinogenesis) in 11 ATLL patients and 20 PTCL-NOS patients and classified them into four stages according to the percentage of positive cells. Among the ATLL cases, 8/11 (73%) were SOX4-positive, while only 2/20 (10%) PTCL-NOS cases expressed SOX4. The mean total score was 4.2 (standard deviation (SD): 0.61) in the ATLL group and 0.50 (SD: 0.46) in the PTCL-NOS group (<i>p</i> < 0.001). Positive expression of p16 was noted in 4/11 (36%) patients with ATLL and 3/20 (15%) patients with PTCL-NOS, with mean total scores of 1.9 (SD: 0.64) and 0.70 (SD: 0.48) in the ATLL and PTCL-NOS groups, respectively (<i>p</i> = 0.141). These results suggest that SOX4 may be strongly expressed in ATLL compared to PTCL-NOS cases. Therefore, it may be helpful to perform immunohistochemical staining of SOX4 when pathologists face challenges discriminating between ATLL and PTCL-NOS.https://www.mdpi.com/2075-4418/11/5/766SOX4p16adult T-cell leukemia/lymphomaperipheral T-cell lymphoma, not otherwise specified
spellingShingle Atsuko Nasu
Yuka Gion
Yoshito Nishimura
Asami Nishikori
Misa Sakamoto
Yuria Egusa
Azusa Fujita
Tadashi Yoshino
Yasuharu Sato
Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
Diagnostics
SOX4
p16
adult T-cell leukemia/lymphoma
peripheral T-cell lymphoma, not otherwise specified
title Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
title_full Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
title_fullStr Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
title_full_unstemmed Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
title_short Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma
title_sort diagnostic utility of sox4 expression in adult t cell leukemia lymphoma
topic SOX4
p16
adult T-cell leukemia/lymphoma
peripheral T-cell lymphoma, not otherwise specified
url https://www.mdpi.com/2075-4418/11/5/766
work_keys_str_mv AT atsukonasu diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT yukagion diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT yoshitonishimura diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT asaminishikori diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT misasakamoto diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT yuriaegusa diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT azusafujita diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT tadashiyoshino diagnosticutilityofsox4expressioninadulttcellleukemialymphoma
AT yasuharusato diagnosticutilityofsox4expressioninadulttcellleukemialymphoma